VMY-1-103

A novel dansylated analog of purvalanol B, and a CDK inhibitor that inhibits cell cycle progression and proliferation in prostate and breast cancer cells more effectively than purvalanol B.

Target : CDK

CAS Number : 1209002-43-6

Formula Weight : 708.27

Molecular Formula : C34H42ClN9O4S

Purity : >98% (HPLC)

Storage : (-20?)

Shipping Conditions : With Ice Pack

Stability : ? 2 years

Research use only, not for human use.